Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Valeria Teresa Barletta, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Cesaro A, Taglialatela V, Gragnano F, Moscarella E, Fimiani F, Conte M, Barletta V, Monda E, Limongelli G, Severino S, Cirillo P, Calabrò P. Low-Dose Ticagrelor in Patients With High Ischemic Risk and Previous Myocardial Infarction: A Multicenter Prospective Real-World Observational Study. J Cardiovasc Pharmacol. 2020 Aug; 76(2):173-180. PMID: 32569017.
  2. Louapre C, Treaba CA, Barletta V, Mainero C. Ultra-high field 7?T imaging in multiple sclerosis. Curr Opin Neurol. 2020 Aug; 33(4):422-429. PMID: 32657883.
  3. Mehndiratta A, Treaba CA, Barletta V, Herranz E, Ouellette R, Sloane JA, Klawiter EC, Kinkel RP, Mainero C. Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRI. Mult Scler. 2020 Jun 25; 1352458520932804. PMID: 32584159.
  4. De Santis S, Herranz E, Treaba CA, Barletta V, Mehndiratta A, Mainero C, Toschi N. Whole brain in vivo axonal diameter mapping in multiple sclerosis. Conf Proc IEEE Eng Med Biol Soc. 2019 07; 2019:204-207. PMID: 31945878.
  5. Barletta VT, Herranz E, Treaba CA, Ouellette R, Mehndiratta A, Loggia ML, Klawiter EC, Ionete C, Jacob SA, Mainero C. Evidence of diffuse cerebellar neuroinflammation in multiple sclerosis by 11C-PBR28 MR-PET. Mult Scler. 2020 05; 26(6):668-678. PMID: 30973800.
  6. De Giglio L, Marinelli F, Barletta VT, Pagano VA, De Angelis F, Fanelli F, Petsas N, Pantano P, Tomassini V, Pozzilli C. Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled Trial. CNS Drugs. 2017 Feb; 31(2):161-168. PMID: 27995531.
    Citations: 1     Fields:    Translation:Humans
  7. Pozzilli C, De Giglio L, Barletta VT, Marinelli F, Angelis FD, Gallo V, Pagano VA, Marini S, Piattella MC, Tomassini V, Pantano P. Oral contraceptives combined with interferon ß in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm. 2015 Aug; 2(4):e120. PMID: 26140279.
    Citations: 9     
  8. Patti F, Pappalardo A, Montanari E, Pesci I, Barletta V, Pozzilli C. Interferon-beta-1a treatment has a positive effect on quality of life of relapsing-remitting multiple sclerosis: results from a longitudinal study. J Neurol Sci. 2014 Feb 15; 337(1-2):180-5. PMID: 24433926.
    Citations: 4     Fields:    Translation:Humans
  9. Prosperini L, Mancinelli CR, De Giglio L, De Angelis F, Barletta V, Pozzilli C. Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis. Mult Scler. 2014 Apr; 20(5):566-76. PMID: 23999607.
    Citations: 12     Fields:    Translation:Humans
  10. Prosperini L, Giannì C, Barletta V, Mancinelli C, Fubelli F, Borriello G, Pozzilli C. Predictors of freedom from disease activity in natalizumab treated-patients with multiple sclerosis. J Neurol Sci. 2012 Dec 15; 323(1-2):104-12. PMID: 23006974.
    Citations: 14     Fields:    Translation:Humans
  11. Prosperini L, Borriello G, De Giglio L, Leonardi L, Barletta V, Pozzilli C. Management of breakthrough disease in patients with multiple sclerosis: when an increasing of Interferon beta dose should be effective? BMC Neurol. 2011 Feb 25; 11:26. PMID: 21352517.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Barletta's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (50)
Co-Authors (6)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.